One Hundred Consecutive Neutropenic Febrile Episodes Demonstrate That CXCR3 Ligands Have Predictive Value in Discriminating the Severity of Infection in …

M Nowak, K Bobeff, J Walenciak, J Kołodrubiec… - Children, 2022 - mdpi.com
This study assesses the value of the CXCR3 ligands CXCL9/MIG, CXCL10/IP-10 and
CXCL11/I-TAC when used to supplement the standard infection markers C-reactive protein …

ALL-258 Association of CXCR3 Receptor Chemokines Serum Levels With the Clinical Course of Febrile Neutropenia Among Children Treated for Cancer

M Nowak, K Bobeff, K Wyka, J Kołodrubiec… - … Myeloma and Leukemia, 2023 - Elsevier
Context Neutropenia is a major risk factor for infection in patients treated with chemotherapy
for cancer. Oligosymptomatic infections during neutropenia prompt the search for new …

The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic …

SM El-Maghraby, MM Moneer, MM Ismail… - Journal of Pediatric …, 2007 - journals.lww.com
Results Neutropenic children with febrile episodes were classified into 2 groups, a group
with unexplainable fever (group I, n= 26) and another group with either blood culture …

The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia

KGE Miedema, ESJM de Bont, RFMO Elferink… - Supportive care in …, 2011 - Springer
Purpose In this study, we evaluated C-reactive protein (CRP), interleukin (IL)-8, procalcitonin
(PCT), and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) as …

The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and …

V Urbonas, A Eidukaitė, I Tamulienė - Cytokine, 2013 - Elsevier
BACKGROUND: Prediction of bacteremia/sepsis in childhood oncology patients with febrile
neutropenia still remains a challenge for the medical community due to the lack of reliable …

Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective …

N Chaudhary, K Kosaraju, K Bhat, I Bairy… - Journal of pediatric …, 2012 - journals.lww.com
Objectives: We evaluated the usefulness of interleukin-6 (IL-6) and C-reactive protein (CRP)
at the onset of febrile neutropenia and 72 hours later, in identifying risk groups and …

Procalcitonin and interleukin-10 may assist in early prediction of bacteraemia in children with cancer and febrile neutropenia

M Doerflinger, GM Haeusler, CSN Li-Wai-Suen… - Frontiers in …, 2021 - frontiersin.org
Objectives Febrile neutropenia (FN) causes treatment disruption and unplanned
hospitalization in children with cancer. Serum biomarkers are infrequently used to stratify …

Serial measurement of interleukin-6 (IL-6) and procalcitonin (PCT) for the determination of bacterial sepsis and outcome in children with febrile neutropenia (FN)

A Sachdeva, SP Yadav, M Anjan… - Journal of Clinical …, 2008 - ascopubs.org
20633 Background: Children with cancer often develop febrile illnesses after chemotherapy.
Determining which children have serious bacterial infections in this vulnerable period would …

Comparison of interleukin-6, interleukin-10, procalcitonin and C-reactive protein in identifying high-risk febrile illness in pediatric cancer patients: a prospective …

XJ Xu, ZB Luo, T Xia, H Song, SL Yang, WQ Xu, YR Ni… - Cytokine, 2019 - Elsevier
The aim of this study is to systematically compare the performance of C-reactive protein
(CRP), procalcitonin (PCT) and serum cytokines in identifying pediatric cancer patients with …

[HTML][HTML] Prospective cohort study of the predictive value of inflammatory biomarkers over clinical variables in children and young people with cancer presenting with …

B Phillips - F1000Research, 2021 - ncbi.nlm.nih.gov
Methods A prospective cohort study was conducted of children under 18 years old, being
treated for cancer or a cancer-like condition, who presented with fever (≥ 38.0 C) and …